150 related articles for article (PubMed ID: 29024630)
1. Improved chemoradiation treatment using trifluridine in human colorectal cancer cells in vitro.
Matsuoka K; Kobunai T; Nukatsuka M; Takechi T
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):249-255. PubMed ID: 29024630
[TBL] [Abstract][Full Text] [Related]
2. Radiosensitisation and enhanced tumour growth delay of colorectal cancer cells by sustained treatment with trifluridine/tipiracil and X-rays.
Rothkamm K; Christiansen S; Rieckmann T; Horn M; Frenzel T; Brinker A; Schumacher U; Stein A; Petersen C; Burdak-Rothkamm S
Cancer Lett; 2020 Nov; 493():179-188. PubMed ID: 32891715
[TBL] [Abstract][Full Text] [Related]
3. Effective Sequential Combined Chemotherapy with Trifluridine/Tipiracil and Regorafenib in Human Colorectal Cancer Cells.
Matsuoka K; Nakagawa F; Tanaka N; Okabe H; Matsuo K; Takechi T
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30257515
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo radiosensitization of colorectal cancer HT-29 cells by the smac mimetic JP-1201.
Huerta S; Gao X; Livingston EH; Kapur P; Sun H; Anthony T
Surgery; 2010 Aug; 148(2):346-53. PubMed ID: 20633731
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, TAS-102, with Oxaliplatin on Human Colorectal and Gastric Cancer Xenografts.
Nukatsuka M; Nakagawa F; Takechi T
Anticancer Res; 2015 Sep; 35(9):4605-15. PubMed ID: 26254349
[TBL] [Abstract][Full Text] [Related]
6. Dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor is an effective radiosensitizer for colorectal cancer.
Chen YH; Wei MF; Wang CW; Lee HW; Pan SL; Gao M; Kuo SH; Cheng AL; Teng CM
Cancer Lett; 2015 Feb; 357(2):582-90. PubMed ID: 25497009
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a Novel Combination Therapy, Based on Trifluridine/Tipiracil and Fruquintinib, against Colorectal Cancer.
Nukatsuka M; Fujioka A; Nagase H; Tanaka G; Hayashi H
Chemotherapy; 2023; 68(2):102-110. PubMed ID: 36623495
[TBL] [Abstract][Full Text] [Related]
8. ChIP-seq Analysis to Explore DNA Replication Profile in Trifluridine-treated Human Colorectal Cancer Cells
Kobunai T; Matsuoka K; Takechi T
Anticancer Res; 2019 Jul; 39(7):3565-3570. PubMed ID: 31262880
[TBL] [Abstract][Full Text] [Related]
9. Trifluridine/Tipiracil plus Oxaliplatin Improves PD-1 Blockade in Colorectal Cancer by Inducing Immunogenic Cell Death and Depleting Macrophages.
Limagne E; Thibaudin M; Nuttin L; Spill A; Derangère V; Fumet JD; Amellal N; Peranzoni E; Cattan V; Ghiringhelli F
Cancer Immunol Res; 2019 Dec; 7(12):1958-1969. PubMed ID: 31611243
[TBL] [Abstract][Full Text] [Related]
10. Effect of a novel oral chemotherapeutic agent containing a combination of trifluridine, tipiracil and the novel triple angiokinase inhibitor nintedanib, on human colorectal cancer xenografts.
Suzuki N; Nakagawa F; Matsuoka K; Takechi T
Oncol Rep; 2016 Dec; 36(6):3123-3130. PubMed ID: 27805254
[TBL] [Abstract][Full Text] [Related]
11. Low dose fractionated radiation enhances the radiosensitization effect of paclitaxel in colorectal tumor cells with mutant p53.
Chendil D; Oakes R; Alcock RA; Patel N; Mayhew C; Mohiuddin M; Gallicchio VS; Ahmed MM
Cancer; 2000 Nov; 89(9):1893-900. PubMed ID: 11064345
[TBL] [Abstract][Full Text] [Related]
12. Safety of trifluridine/tipiracil in an open-label expanded-access program in elderly and younger patients with metastatic colorectal cancer.
Mayer RJ; Hochster HS; Cohen SJ; Winkler R; Makris L; Grothey A
Cancer Chemother Pharmacol; 2018 Dec; 82(6):961-969. PubMed ID: 30350179
[TBL] [Abstract][Full Text] [Related]
13. Relationship Between Thymidine Kinase 1 Expression and Trifluridine/Tipiracil Therapy in Refractory Metastatic Colorectal Cancer: A Pooled Analysis of 2 Randomized Clinical Trials.
Yoshino T; Yamazaki K; Shinozaki E; Komatsu Y; Nishina T; Baba H; Tsuji A; Tsuji Y; Yamaguchi K; Sugimoto N; Denda T; Muro K; Takayama T; Esaki T; Hamamoto Y; Moriwaki T; Shimada Y; Goto M; Nakayama N; Fujii H; Tanase T; Ohtsu A
Clin Colorectal Cancer; 2018 Dec; 17(4):e719-e732. PubMed ID: 30172759
[TBL] [Abstract][Full Text] [Related]
14. Monitoring trifluridine incorporation in the peripheral blood mononuclear cells of colorectal cancer patients under trifluridine/tipiracil medication.
Nakanishi R; Kitao H; Kiniwa M; Morodomi Y; Iimori M; Kurashige J; Sugiyama M; Nakashima Y; Saeki H; Oki E; Maehara Y
Sci Rep; 2017 Dec; 7(1):16969. PubMed ID: 29208954
[TBL] [Abstract][Full Text] [Related]
15. TAS-116, a Novel Hsp90 Inhibitor, Selectively Enhances Radiosensitivity of Human Cancer Cells to X-rays and Carbon Ion Radiation.
Lee Y; Sunada S; Hirakawa H; Fujimori A; Nickoloff JA; Okayasu R
Mol Cancer Ther; 2017 Jan; 16(1):16-24. PubMed ID: 28062703
[TBL] [Abstract][Full Text] [Related]
16. Anti-cancer effects of chemotherapeutic agent; 17-AAG, in combined with gold nanoparticles and irradiation in human colorectal cancer cells.
Moradi Z; Mohammadian M; Saberi H; Ebrahimifar M; Mohammadi Z; Ebrahimpour M; Behrouzkia Z
Daru; 2019 Jun; 27(1):111-119. PubMed ID: 30835081
[TBL] [Abstract][Full Text] [Related]
17. Cyclin-dependent kinase 1 targeting improves sensitivity to radiation in BRAF V600E colorectal carcinoma cells.
Spagnoletti G; Li Bergolis V; Piscazzi A; Giannelli F; Condelli V; Sisinni L; Bove G; Storto G; Landriscina M
Tumour Biol; 2018 Apr; 40(4):1010428318770957. PubMed ID: 29663854
[TBL] [Abstract][Full Text] [Related]
18. Targeting ARID1A-mutant colorectal cancer: depletion of ARID1B increases radiosensitivity and modulates DNA damage response.
Niedermaier B; Sak A; Zernickel E; Xu S; Groneberg M; Stuschke M
Sci Rep; 2019 Dec; 9(1):18207. PubMed ID: 31796878
[TBL] [Abstract][Full Text] [Related]
19. Real-world Treatment Patterns Among Patients With Colorectal Cancer Treated With Trifluridine/Tipiracil and Regorafenib.
Patel AK; Duh MS; Barghout V; Yenikomshian MA; Xiao Y; Wynant W; Tabesh M; Fuchs CS
Clin Colorectal Cancer; 2018 Sep; 17(3):e531-e539. PubMed ID: 29803544
[TBL] [Abstract][Full Text] [Related]
20. Crucial roles of thymidine kinase 1 and deoxyUTPase in incorporating the antineoplastic nucleosides trifluridine and 2'-deoxy-5-fluorouridine into DNA.
Sakamoto K; Yokogawa T; Ueno H; Oguchi K; Kazuno H; Ishida K; Tanaka N; Osada A; Yamada Y; Okabe H; Matsuo K
Int J Oncol; 2015; 46(6):2327-34. PubMed ID: 25901475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
